Bluebird bio Inc (BLUE) Company Profile & Statistics

Bluebird bio Inc
BLUE
(Nasdaq - US)
Closed
0.35
+0.05 (+16.75%)
in:usd•As of: Nov 22, 2024 15:59 UTC -5
After Market:0.3571+0.01 (+2.67%)
Open
0.31
High
0.36
Low
0.31

About Bluebird bio Inc

CEO

Andrew Obenshain

Headquarters

455 grand union boulevard

somerville, ma 02145, united states

Auditor

Ernst & Young LLP

Employees

375

Share Holders

Website

www.bluebirdbio.com

Industry

biotechnology

Sector

health technology

Company Overview

bluebird bio, Inc. is a clinical-stage biotechnology that is focused on developing gene therapies for severe genetic diseases and cancer. The company has developed a deep pipeline using lentiviral-based gene therapies, T-cell immunotherapy expertise, and gene editing capabilities to treat severe genetic diseases as well as cancer.?The pipeline for severe genetic diseases includes betibeglogene autotemcel (beti-cel) for the treatment of transfusion-dependent ?-thalassemia (TDT).

Bluebird bio Inc Statistics

Valuation Measures

Market Capitalization ²	67.63M
Enterprise Value	179.51M
Enterprise Value/EBITDA (ttm)	-0.68
Price to Earnings Ratio (ttm)	N/A
Price to Book (mrq)	N/A
Price to Sales (ttm)	1.09
Price to Cash (ytd)	N/A

Profitability

Gross Margin (ttm)	-46.42%
Operating Margin (ttm)	-565.74%
Profit Margin (ttm)	-621.51%
Return on Equity (ttm)	-322.46%
Return on Invested Capital (ttm)	54590.91%
Return on Assets (ttm)	-53.17%

Income Statement

Revenue (ttm)	53.12M
Revenue Per Share (ttm)	0.27
Gross Profit (ttm)	-25.66M
EBITDA (ttm)³	-265.08M
Net Income Avi to Common (ttm)	-292.83M
Diluted EPS (ttm)	-1.87

Share Statistics

Beta (5Y Monthly)	0.76
52-Week Change	-90.92%
S&P500 52-Week Change	30.93%
S&P500 Member	No
Stock Optionable	Yes
Total Shares Outstanding ¹	194.44M
Dividend Yield	0.00%
Float ⁴	191.72M
% Held by Insiders	1.40%
% Held by Institutions	87.43%

Balance Sheet

Total Cash (mrq)	70.65M
Total Cash Per Share (mrq)	0.36
Total Debt (mrq)	182.54M
Total Debt/Equity (mrq)	-3154.79%
Current Ratio (mrq)	0.51%
Quick Ratio (mrq)	0.33%
Book Value Per Share (mrq)	-0.03

Cash Flow

Operating Cash Flow Per Share (ytd)	-1.08
Free Cash Flow (ytd)	-211.97M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. Stock price provided by Xignite. All numbers are rounded to the closest decimal.

¹ Total Shares outstanding is taken from the most recently filed quarterly or annual report.

² Market Cap is calculated using total shares outstanding and the most recent share price.

³ EBITDA is calculated using methodology that may differ from that used by a company in its reporting.

⁴ The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

Bluebird bio Inc

Trade With A Regulated Broker